早期检测血浆相关磷脂酶A2在缺血性脑卒中患者中的应用价值

Value of Early Detection of Plasma Associated Phospholipase A2 in Patients with Ischemic Stroke

目的:研究早期检测血浆相关磷脂酶A2在缺血性脑卒中患者中的应用价值。方法:选取某院收治的32例缺血性脑卒中患者作为研究对象设为研究组,另选取同期进行常规体检的32例健康者作为对照研究对象设为对照组,两组均行血浆相关磷脂酶A2检测,对比分析其检测结果。结果:研究组的总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇与血浆相关磷脂酶A2水平均明显高于对照组,对比差异显著(P<0.05)。缺血性脑卒中患者急性期的血浆相关磷脂酶A2水平明显高于恢复期与后遗症期,恢复期的血浆相关磷脂酶A2水平明显高于后遗症期,对比差异均显著(P<0.05)。结论:缺血性脑卒中患者的血浆相关磷脂酶A2水平明显升高,早期进行血浆相关磷脂酶A2检测,可为临床诊治提供参考依据。

Objective： To investigate the value of early detection of plasma associated phospholipase A2 in patients with ischemic stroke. Methods： 32 cases of ischemic stroke patients in a hospital was selected as the study group, 32 healthy cases were selected for routine physical examination in a hospital as the control subjects, as control group.Two groups were treated with plasma associated phospholipase A2 detection, comparatively analyzed the test results. Results： The total cholesterol,three triglyceride,high density lipoprotein cholesterol,low density lipoprotein cholesterol and plasma associated phospholipase A2 levels of the study group were significantly higher than the control group, comparative differences were significant （ P 〈0.05）. Patients with acute ischemic stroke of the plasma associated phospholipase A2 levels were significantly higher than that of the recovery period and sequelae period, recovery period of plasma associated phospholipase A2 levels were significantly higher than that of sequelae, comparative differences were significant （ P 〈0.05）. Conclusion： Plasma phospholipase A2 levels in patients with ischemic stroke are significantly increase, and plasma associated phospholipase A2 testing at early stage can provide a reference for clinical diagnosis and treatment.